Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025

Between December 2024 and August 2025, two Italian HIV/STI clinics offered long-acting injectable cabotegravir (CAB-LA) for HIV prevention in 265 individuals, representing the first European real-world implementation. Participants were prioritised based on vulnerabilities compromising oral pre-expos...

Full description

Bibliographic Details

Published in:	Eurosurveillance
Main Author:	Valentina Mazzotta
Format:	Article
Language:	English
Published:	European Centre for Disease Prevention and Control 2025-10-01
Subjects:	pre-exposure prophylaxis implementation PrEP real-world evidence HIV cabotegravir
Online Access:	https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2025.30.39.2500739